Doctor profile · Federal record
Dr. Catherine Meriwether, MSN NP
Nurse Practitioner · Franklin, TN
- NPI 1467757609
- Accepts Medicare
- 16 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
125 Cool Springs Blvd Ste 210
Franklin, TN 370674637
(615) 716-1611
fax (629) 206-2511 - Mailing address
-
820 Springer Dr
Lombard, IL 601486413
Credentials & registration
- NPI registered
- January 2011 — 15 yrs on file
- Profile last updated
- August 28, 2024
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Tennessee #15553
- Medicaid
- TN #1522959
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1467757609. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
645
Distinct HCPCS
7
Medicare allowed
$24,617
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 275 | 53 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 100 | 83 | $71 | |
17110 |
Destruction of skin growth, 1-14 growths | 88 | 72 | $87 | |
17000 |
Destruction of precancer skin growth, 1 growth | 84 | 67 | $37 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 62 | 56 | $44 | |
11102 |
Biopsy of related skin growth, first growth | 21 | 20 | $60 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 15 | 15 | $88 |
In context: peer comparison
Among 5 peers in Franklin Nurse Practitioner, average services per provider: 169. This provider delivers 3.8× the peer median.Open Payments
Industry payments received
All-time total
$3,443
Transactions
159
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 34 | $742.78 | |
| Sun Pharmaceutical Industries INC. | 31 | $472.73 | |
| Novartis Pharmaceuticals Corporation | 17 | $382.66 | |
| Ucb, INC. | 13 | $320.77 | |
| Janssen Biotech, INC. | 16 | $226.43 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 5 | $158.45 | |
| Genzyme Corporation | 9 | $154.15 | |
| Lilly USA, LLC | 7 | $148.01 | |
| Regeneron Healthcare Solutions, INC. | 6 | $145.68 | |
| Amgen INC. | 7 | $143.59 | |
| Leo Pharma INC. | 2 | $90.87 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 3 | $78.73 | |
| Galderma Laboratories, L.P. | 4 | $74.09 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $73.93 | |
| Kerecis Limited | 1 | $54.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
267
Patients
143
Total drug cost
$10,741
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 64 | 31 | $2,566 |
| Triamcinolone Acetonide | Generic | 43 | 38 | $572 |
| Fluorouracil | Generic | 31 | 27 | $3,619 |
| Clobetasol Propionate | Generic | 30 | 19 | $2,312 |
| Doxycycline Hyclate | Generic | 20 | 11 | $359 |
| Hydrocortisone | Generic | 17 | 17 | $126 |
| Spironolactone | Generic | 14 | 0 | $270 |
| Hydroxyzine Hcl | Generic | 13 | 0 | $54 |
| Mupirocin | Generic | 13 | 0 | $98 |
| Clindamycin Phosphate | Generic | 11 | 0 | $436 |
Frequently asked questions
What is Dr. Catherine Meriwether's medical specialty?
Dr. Catherine Meriwether practices Nurse Practitioner in Franklin, TN.
Where does Dr. Catherine Meriwether practice?
Dr. Catherine Meriwether practices at 125 Cool Springs Blvd Ste 210, Franklin, TN 370674637. Office phone: 6157161611.
What is Dr. Catherine Meriwether's NPI?
Dr. Catherine Meriwether's National Provider Identifier (NPI) is 1467757609, issued by NPPES.
Does Dr. Catherine Meriwether accept Medicare assignment?
Yes. Dr. Catherine Meriwether accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Catherine Meriwether commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of skin growth, 1-14 growths (HCPCS 17110). Source: CMS Medicare Physician & Other Practitioners file.